Key Takeaways
- Shares of AVAV climbed 2.9% Tuesday to close at $148.78 with trading volume 24% above average, though the stock remains beneath key technical levels.
- The company announces Q1 2027 results Wednesday, September 9th post-market, with Wall Street projecting $0.25 per share, representing a 21.9% yearly decline.
- Quarterly revenue projections sit at $456.09M, reflecting minimal 0.3% growth versus last year’s comparable quarter.
- Analyst sentiment has deteriorated with 11 consecutive EPS estimate reductions over three months and no upward adjustments.
- Wall Street maintains a bullish stance with a “Moderate Buy” consensus and $266.68 average target price, substantially above current levels.
AeroVironment prepares to unveil its fiscal Q1 2027 financial results following Wednesday’s market close on September 9th. Wall Street forecasts earnings per share of $0.25, marking a significant 21.9% contraction from the year-ago period.
Quarterly revenue projections are calling for $456.09 million, essentially stagnant with only a marginal 0.3% year-over-year uptick anticipated.
Tuesday’s session saw the stock finish at $148.78 following an intraday peak of $152.20. Trading activity registered approximately 1.98 million shares, running roughly 24% higher than typical daily levels.
Even with Tuesday’s gains, AVAV continues trading significantly beneath both its 50-day moving average at $160.13 and 200-day moving average at $181.64. This technical positioning suggests vulnerability ahead of the quarterly announcement.
Declining Estimates Signal Analyst Concern
The pattern of estimate changes preceding this release raises red flags. Throughout the previous three-month window, earnings projections faced 11 downward adjustments with zero upward movements. Revenue forecasts mirrored this pessimism, experiencing 10 reductions without any positive revisions.
Such uniformly negative revision momentum typically indicates analyst apprehension regarding upcoming performance.
Nevertheless, AVAV maintains an impressive track record on the revenue front. Across the preceding two years, the firm exceeded revenue projections 75% of the time. Earnings surprises prove less reliable, achieving beats just 38% during the identical timeframe.
The previous quarter showcased exceptional performance. Q4 earnings reached $1.84 per share compared to the $1.47 forecast, while revenue totaled $641.62 million against consensus of $555.97 million, surging 133.3% annually.
That quarter represented an outlier. Current Q1 projections reflect considerably more conservative expectations.
Wall Street Price Objectives Suggest Significant Upside
Although multiple firms have reduced their price objectives lately, the broader Street perspective on AVAV stays constructive. Consensus opinion registers as “Moderate Buy,” supported by 18 Buy recommendations, 2 Strong Buys, 3 Hold ratings, and 1 Sell.
The mean price objective stands at $266.68, indicating considerable appreciation potential from current trading levels.
Canaccord Genuity lowered its objective from $280 to $240 in July while retaining its Buy recommendation. Stifel Nicolaus reduced its target from $315 to $220, likewise preserving its Buy stance. Piper Sandler adjusted downward from $248 to $235 accompanied by an Overweight rating. Wedbush initiated coverage with an Outperform designation and $250 objective.
Institutional holders control 86.38% of outstanding shares. Meanwhile, company insiders have demonstrated net selling activity, offloading 705 shares during the past three months valued at approximately $132,979.
Management’s full-year FY2027 EPS guidance spans $3.02 to $3.34, with analyst consensus clustering around $3.20 for the complete fiscal period.
Wednesday’s quarterly disclosure will reveal whether Q1 performance positions AVAV to achieve these annual targets.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
